Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users

INTRODUCTION[|]This study aims to investigate the relationship between smokeless tobacco (maras powder) consumption and otorhinolaryngological symptoms.[¤]METHODS[|]This descriptive study was carried out on 599 participants. The participants were divided into two groups. Of these, 299 (49.9%) patien...

Full description

Bibliographic Details
Main Authors: Saime Sağıroğlu, Ayşegül Erdoğan, Adem Doğaner, Ramazan Azim Okyay
Format: Article
Language:English
Published: KARE Publishing 2019-09-01
Series:İstanbul Kuzey Klinikleri
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-50024
id doaj-adc2174f1de04fa6bd3ab069b01f0275
record_format Article
spelling doaj-adc2174f1de04fa6bd3ab069b01f02752021-01-24T18:40:53ZengKARE Publishingİstanbul Kuzey Klinikleri2148-49022019-09-016328429210.14744/nci.2018.50024NCI-50024Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) usersSaime Sağıroğlu0Ayşegül Erdoğan1Adem Doğaner2Ramazan Azim Okyay3Department of Otorhinolaringology, Kahramanmaras Sutcu Imam University Faculty of Medicine, Kahramanmaras, TurkeyDepartment of Public Health, Kahramanmaras Sutcu Imam University Faculty of Medicine, Kahramanmaras, TurkeyDepartment of Biostatistics and Medical Informatics, Kahramanmaras Sutcu Imam University Faculty of Medicine, Kahramanmaras, TurkeyDepartment of Public Health, Kahramanmaras Sutcu Imam University Faculty of Medicine, Kahramanmaras, TurkeyINTRODUCTION[|]This study aims to investigate the relationship between smokeless tobacco (maras powder) consumption and otorhinolaryngological symptoms.[¤]METHODS[|]This descriptive study was carried out on 599 participants. The participants were divided into two groups. Of these, 299 (49.9%) patients aged over 18 years were the first group; they used smokeless tobacco for at least 5 years. The remaining patients comprised the second group, which included 300 (50.1%) healthy volunteers who did not use tobacco or its products and demonstrated some similarities with the first group. For the purpose of data collection, a questionnaire consisting of 45 questions was administered to the participants. [¤]RESULTS[|]Cough, sputum, shortness of breath, dysphagia, snoring, and apnea-hypopnea were found to be significantly increased in smokeless tobacco users. The highest odds ratio (OR) found was for sputum at 2.615. Similarly, other oral cavity symptoms such as mouth tickling, dryness of throat, mouth sores, halitosis, taste disorders, and toothache were found to be significantly increased in smokeless tobacco users. It is noteworthy that halitosis was 9.4 times more prevalent among smokeless tobacco users than in the non-tobacco users. Sinonasal symptoms such as sneezing, headache, facial fullness, and anorexia were found to be significantly increased in smokeless tobacco users. However, there were no differences between the groups in terms of ear symptoms. [¤]DISCUSSION AND CONCLUSION[|]This study demonstrated that the negative effects of smokeless tobacco consumption were particularly higher in the oral cavity, which in turn gave rise to a number of serious upper respiratory tract complaints. [¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-50024maras powderotorhinolaryngology; smokeless tobacco; symptoms.
collection DOAJ
language English
format Article
sources DOAJ
author Saime Sağıroğlu
Ayşegül Erdoğan
Adem Doğaner
Ramazan Azim Okyay
spellingShingle Saime Sağıroğlu
Ayşegül Erdoğan
Adem Doğaner
Ramazan Azim Okyay
Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users
İstanbul Kuzey Klinikleri
maras powder
otorhinolaryngology; smokeless tobacco; symptoms.
author_facet Saime Sağıroğlu
Ayşegül Erdoğan
Adem Doğaner
Ramazan Azim Okyay
author_sort Saime Sağıroğlu
title Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users
title_short Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users
title_full Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users
title_fullStr Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users
title_full_unstemmed Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users
title_sort otorhinolaryngological symptoms among smokeless tobacco (maras powder) users
publisher KARE Publishing
series İstanbul Kuzey Klinikleri
issn 2148-4902
publishDate 2019-09-01
description INTRODUCTION[|]This study aims to investigate the relationship between smokeless tobacco (maras powder) consumption and otorhinolaryngological symptoms.[¤]METHODS[|]This descriptive study was carried out on 599 participants. The participants were divided into two groups. Of these, 299 (49.9%) patients aged over 18 years were the first group; they used smokeless tobacco for at least 5 years. The remaining patients comprised the second group, which included 300 (50.1%) healthy volunteers who did not use tobacco or its products and demonstrated some similarities with the first group. For the purpose of data collection, a questionnaire consisting of 45 questions was administered to the participants. [¤]RESULTS[|]Cough, sputum, shortness of breath, dysphagia, snoring, and apnea-hypopnea were found to be significantly increased in smokeless tobacco users. The highest odds ratio (OR) found was for sputum at 2.615. Similarly, other oral cavity symptoms such as mouth tickling, dryness of throat, mouth sores, halitosis, taste disorders, and toothache were found to be significantly increased in smokeless tobacco users. It is noteworthy that halitosis was 9.4 times more prevalent among smokeless tobacco users than in the non-tobacco users. Sinonasal symptoms such as sneezing, headache, facial fullness, and anorexia were found to be significantly increased in smokeless tobacco users. However, there were no differences between the groups in terms of ear symptoms. [¤]DISCUSSION AND CONCLUSION[|]This study demonstrated that the negative effects of smokeless tobacco consumption were particularly higher in the oral cavity, which in turn gave rise to a number of serious upper respiratory tract complaints. [¤]
topic maras powder
otorhinolaryngology; smokeless tobacco; symptoms.
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-50024
work_keys_str_mv AT saimesagıroglu otorhinolaryngologicalsymptomsamongsmokelesstobaccomaraspowderusers
AT aysegulerdogan otorhinolaryngologicalsymptomsamongsmokelesstobaccomaraspowderusers
AT ademdoganer otorhinolaryngologicalsymptomsamongsmokelesstobaccomaraspowderusers
AT ramazanazimokyay otorhinolaryngologicalsymptomsamongsmokelesstobaccomaraspowderusers
_version_ 1724324946014896128